Huaren Pharmaceutical Co., Ltd. (300110.SZ) SHZ

3.25

+0.01(+0.31%)

Updated at October 20 10:32AM

Currency In CNY

Valuation

Market Cap4.16B
Enterprise Value4.89B
P/E Ratio-2.72
PEG Ratio-0.03
Price/Sales Ratio3.18
Price/Book Ratio2.85
Enterprise/Revenue3.74
Enterprise/EBITDA-3.33

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-1.16
Operating Margin-1.15

Management Effectiveness

Return On Assets-0.41
Return On Equity-0.84

Income Statement

Revenue1.35B
Revenue/Share1.02
Gross Profit476.33M
EBITDA-1.18B
Net Income-1.37B
Diluted EPS-1.16

Balance Sheet

Total Cash211.06M
Total Cash/Share0.18
Total Debt888.96M
Total Debt/Equity0.66
Current Ratio0.74
Book Value Per Share1.2

Price History

52-Week Change-8.73
52-Week High4.2
52-Week Low2.71
Moving Average 50 Days3.38
Moving Average 200 Days3.26

Statistics

Average Volume27.01M
Shares Outstanding1.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split Factor287:250
Last Split DateFebruary 09, 2018